Trial intelligence / Profile preview

Vraylar in Social Anxiety Disorder

NCT05384483Phase 4Completed

Sponsor
Medical Research Network
Start
Jul 2022
Primary completion
Apr 2024
Modality
Orthosteric Ligands
Countries
1
01

Overview

A Phase 4 trial of cariprazine in Social Anxiety Disorder (SAD), sponsored by Medical Research Network. Started Jul 2022; status: completed.

02

Drugs

cariprazine
03

Conditions

Social Anxiety Disorder (SAD)

Beyond the preview

Go deeper on NCT05384483.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT05384483.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call